サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1426472

妊娠性絨毛疾患の世界市場レポート 2024

Gestational Trophoblastic Disease Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
妊娠性絨毛疾患の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

妊娠性絨毛疾患の市場規模は、今後数年間で着実に成長すると予想されています。 2028年には4.8%の年間複合成長率（CAGR）で24億9,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、ヘルスケアインフラの開発、遠隔医療と遠隔医療の進歩、患者中心の治療アプローチの採用、新しい治療法の規制当局の承認、ゲノム研究と分子研究の進歩に起因すると考えられます。予測期間中に予想される主な動向には、個別化医療への移行、分子診断の進歩、免疫療法と標的療法への焦点、デジタルヘルステクノロジーの統合、意識向上と教育プログラムの増加が含まれます。

妊娠性絨毛疾患市場は、異常妊娠の増加により成長が見込まれています。典型的な経過から逸脱した異常な妊娠は、母親と胎児の両方に健康リスクをもたらし、特に奇胎妊娠などの場合、妊娠性絨毛疾患につながる可能性があります。たとえば、英国政府は、2020年から2021年にかけて英国で報告された中絶件数が1.73%増加し、全妊娠の約25%が中絶に終わったと報告しました。中絶率の上昇が示すように、この異常妊娠の急増は、妊娠性絨毛疾患市場の主要な促進要因となっています。

妊娠性絨毛疾患市場の成長は、喫煙率の増加によってさらに加速されています。有害な影響があることで知られるタバコの喫煙は、妊娠性絨毛疾患の開発に関連しています。タバコの煙に含まれる化学物質は栄養膜細胞のDNAを損傷し、異常な増殖と分裂を引き起こし、妊娠性絨毛疾患を発症する可能性があります。たとえば、カナダ統計局は、2021年 8月から2022年 8月にかけてカナダの紙巻きタバコ生産量が45.2%増加したと報告しています。同時の紙巻きタバコ消費量の増加は、喫煙と妊娠性絨毛疾患との関連性を強化し、市場の成長に貢献しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の妊娠性絨毛疾患市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 胞状奇胎
  • 絨毛がん
  • 胎盤部位のトロホブラスティック腫瘍
  • 類上皮性栄養膜腫瘍
  • その他のタイプ
  • 世界の妊娠性絨毛疾患市場、治療別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 手術
  • 化学療法
  • 吸引拡張と掻爬（D&C）
  • 放射線治療
  • 世界の妊娠性絨毛疾患市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院とクリニック
  • 診断センター
  • その他のエンドユーザー

第7章 地域および国の分析

  • 世界の妊娠性絨毛疾患市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の妊娠性絨毛疾患市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 妊娠性絨毛疾患市場の競合情勢
  • 妊娠性絨毛疾患市場企業プロファイル
    • Pfizer Inc.
    • F. Hoffmann-La Roche AG
    • AbbVie Inc.
    • Bayer AG
    • Novartis AG

第31章 その他の大手および革新的な企業

  • Merck And Co. Inc.
  • Sun Pharmaceutical Industries Ltd.
  • GSK plc
  • Bristol-Myers Squibb Company
  • Sanofi SA
  • AstraZeneca plc
  • Eli Lilly and Company
  • Mylan NV
  • Daiichi Sankyo Co. Ltd.
  • Eisai Co. Ltd.
  • Perrigo Company plc
  • Jiangsu Hengrui Medicine Co. Ltd.
  • Exelixis Inc.
  • Wockhardt Ltd.
  • Natco Pharma Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13484

Gestational trophoblastic disease (GTD) encompasses a group of rare and abnormal conditions arising from the anomalous growth of trophoblastic cells, leading to the formation of a tumor within the uterus following conception. The treatment for GTD typically involves uterine evacuation and the ongoing monitoring of human chorionic gonadotropin (hCG) levels.

The main types of gestational trophoblastic disease include hydatidiform mole, choriocarcinoma, placental-site trophoblastic tumor, epithelioid trophoblastic tumor, and others. A hydatidiform mole, also referred to as a molar pregnancy, is an uncommon and abnormal pregnancy condition. Treatment options for this condition include surgery, chemotherapy, suction dilation and curettage (D&C), and radiation therapy. These treatments are administered by various end-users such as hospitals, clinics, diagnostic centers, and others.

The gestational trophoblastic disease market research report is one of a series of new reports from The Business Research Company that provides gestational trophoblastic disease market statistics, including gestational trophoblastic disease industry global market size, regional shares, competitors with a gestational trophoblastic disease market share, detailed gestational trophoblastic disease market segments, market trends and opportunities, and any further data you may need to thrive in the gestational trophoblastic disease industry. This gestational trophoblastic disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gestational trophoblastic disease market size has grown strongly in recent years. It will grow from $1.96 billion in 2023 to $2.06 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The growth observed in the historical period can be attributed to public health initiatives, an enhanced understanding of disease pathology, advancements in medical research and clinical trials, the development of targeted therapies, and a shift in treatment protocols.

The gestational trophoblastic disease market size is expected to see steady growth in the next few years. It will grow to $2.49 billion in 2028 at a compound annual growth rate (CAGR) of 4.8%. The anticipated growth in the forecast period can be attributed to healthcare infrastructure development, the advancement of telemedicine and remote care, the adoption of patient-centric care approaches, regulatory approvals for novel treatments, and the progress in genomic and molecular studies. Major trends expected in the forecast period include a shift towards personalized medicine, advancements in molecular diagnostics, a focus on immunotherapies and targeted therapies, the integration of digital health technologies, and the rise of awareness and education programs.

The gestational trophoblastic disease market is anticipated to witness growth due to the increasing prevalence of abnormal pregnancies. Abnormal pregnancies, deviating from the typical course, pose health risks to both the mother and the fetus, potentially leading to gestational trophoblastic disease, especially in cases such as molar pregnancies. For instance, Gov.UK reported a 1.73% increase in reported abortions in Great Britain from 2020 to 2021, with around 25% of all pregnancies ending in abortion. This surge in abnormal pregnancies, as indicated by the rising abortion rates, is a key driver for the gestational trophoblastic disease market.

The growth of the gestational trophoblastic disease market is further fueled by the increasing prevalence of cigarette smoking. Cigarette smoking, known for its harmful effects, is linked to the development of gestational trophoblastic disease. The chemicals in tobacco smoke can damage trophoblastic cell DNA, leading to abnormal growth and division and the onset of gestational trophoblastic disease. For example, Statistics Canada reported a notable 45.2% increase in cigarette production in Canada from August 2021 to August 2022. The concurrent rise in cigarette consumption reinforces the association between smoking and gestational trophoblastic disease, contributing to market growth.

The gestational trophoblastic disease market faces challenges due to low awareness and diagnosis rates. Limited knowledge among healthcare professionals and individuals may result in delayed or missed diagnoses of gestational trophoblastic disease, impacting timely intervention and patient outcomes. The American Society of Clinical Oncology reported an annual incidence of 110 to 120 cases per 100,000 pregnancies for gestational trophoblastic disease, emphasizing the need for increased awareness. The low awareness and diagnosis rates present a significant hurdle to the gestational trophoblastic disease market's growth.

Major companies operating in the gestational trophoblastic disease market are introducing updated guidelines to enhance services. The Health Service Executive National Cancer Control Programme in Ireland launched an updated gestational trophoblastic disease guideline, aiming to provide comprehensive insights into diagnostic and management strategies. By reducing practice variation and improving the quality of care, these guidelines contribute to better outcomes for gestational trophoblastic disease patients.

Companies in the gestational trophoblastic disease market are innovating treatments, such as reproductive tissue preservation solutions, to offer reliable services. Reproductive tissue preservation solutions, preserving the viability of reproductive tissue, provide flexibility and control over family-building choices. Inception Fertility introduced HavenCryo, a long-term reproductive tissue and cryopreservation storage solution, allowing indefinite storage of eggs, sperm, and embryos. This solution proves beneficial for individuals diagnosed with gestational trophoblastic disease who need fertility preservation before undergoing treatments that may impact fertility.

Major companies operating in the gestational trophoblastic disease market report are Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Bayer AG, Novartis AG, Merck And Co. Inc., Sun Pharmaceutical Industries Ltd., GSK plc, Bristol-Myers Squibb Company, Sanofi S.A., AstraZeneca plc, Eli Lilly and Company, Mylan N.V, Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Perrigo Company plc, Jiangsu Hengrui Medicine Co. Ltd., Exelixis Inc., Wockhardt Ltd., Natco Pharma Ltd., Blueprint Medicines Corporation, Array BioPharma Inc., Deciphera Pharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Boston Biomedical Inc., DNAtrix Inc., Arog Pharmaceuticals Inc., Advenchen Laboratories LLC., Mendus AB, AB Science S.A.

Asia-Pacific was the largest region in the gestational trophoblastic disease market in 2022, and is expected to be the fastest-growing region in the forecast period. The regions covered in the gestational trophoblastic disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the gestational trophoblastic disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The gestational trophoblastic disease market consists of revenues earned by entities by providing services such as gynecology services, oncology services, and surgical services. The market value includes the value of related goods sold by the service provider or included within the service offering. The gestational trophoblastic disease market also includes sales of medications, diagnostic tools, laboratory tests, methotrexate, etoposide, cyclophosphamide, and vincristine. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gestational Trophoblastic Disease Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gestational trophoblastic disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gestational trophoblastic disease? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gestational trophoblastic disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Hydatidiform Mole; Choriocarcinoma; Placental-Site Trophoblastic Tumor; Epithelioid Trophoblastic Tumor; Other Types
  • 2) By Treatment: Surgery; Chemotherapy; Suction Dilation And Curettage (D&C); Radiation Therapy
  • 3) By End User: Hospital And Clinics; Diagnostic Centers; Other End Users
  • Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; AbbVie Inc.; Bayer AG; Novartis AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gestational Trophoblastic Disease Market Characteristics

3. Gestational Trophoblastic Disease Market Trends And Strategies

4. Gestational Trophoblastic Disease Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Gestational Trophoblastic Disease Market Size and Growth

  • 5.1. Global Gestational Trophoblastic Disease Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Gestational Trophoblastic Disease Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Gestational Trophoblastic Disease Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Gestational Trophoblastic Disease Market Segmentation

  • 6.1. Global Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hydatidiform Mole
  • Choriocarcinoma
  • Placental-Site Trophoblastic Tumor
  • Epithelioid Trophoblastic Tumor
  • Other Types
  • 6.2. Global Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Surgery
  • Chemotherapy
  • Suction Dilation And Curettage (D&C)
  • Radiation Therapy
  • 6.3. Global Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital And Clinics
  • Diagnostic Centers
  • Other End Users

7. Gestational Trophoblastic Disease Market Regional And Country Analysis

  • 7.1. Global Gestational Trophoblastic Disease Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Gestational Trophoblastic Disease Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Gestational Trophoblastic Disease Market

  • 8.1. Asia-Pacific Gestational Trophoblastic Disease Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Gestational Trophoblastic Disease Market

  • 9.1. China Gestational Trophoblastic Disease Market Overview
  • 9.2. China Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Gestational Trophoblastic Disease Market

  • 10.1. India Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Gestational Trophoblastic Disease Market

  • 11.1. Japan Gestational Trophoblastic Disease Market Overview
  • 11.2. Japan Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Gestational Trophoblastic Disease Market

  • 12.1. Australia Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Gestational Trophoblastic Disease Market

  • 13.1. Indonesia Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Gestational Trophoblastic Disease Market

  • 14.1. South Korea Gestational Trophoblastic Disease Market Overview
  • 14.2. South Korea Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Gestational Trophoblastic Disease Market

  • 15.1. Western Europe Gestational Trophoblastic Disease Market Overview
  • 15.2. Western Europe Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Gestational Trophoblastic Disease Market

  • 16.1. UK Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Gestational Trophoblastic Disease Market

  • 17.1. Germany Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Gestational Trophoblastic Disease Market

  • 18.5. France Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Gestational Trophoblastic Disease Market

  • 19.9. Italy Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Gestational Trophoblastic Disease Market

  • 20.13. Spain Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Gestational Trophoblastic Disease Market

  • 21.1. Eastern Europe Gestational Trophoblastic Disease Market Overview
  • 21.2. Eastern Europe Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Gestational Trophoblastic Disease Market

  • 22.1. Russia Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Gestational Trophoblastic Disease Market

  • 23.1. North America Gestational Trophoblastic Disease Market Overview
  • 23.2. North America Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Gestational Trophoblastic Disease Market

  • 24.1. USA Gestational Trophoblastic Disease Market Overview
  • 24.2. USA Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Gestational Trophoblastic Disease Market

  • 25.1. Canada Gestational Trophoblastic Disease Market Overview
  • 25.2. Canada Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Gestational Trophoblastic Disease Market

  • 26.1. South America Gestational Trophoblastic Disease Market Overview
  • 26.2. South America Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Gestational Trophoblastic Disease Market

  • 27.1. Brazil Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Gestational Trophoblastic Disease Market

  • 28.1. Middle East Gestational Trophoblastic Disease Market Overview
  • 28.2. Middle East Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Gestational Trophoblastic Disease Market

  • 29.1. Africa Gestational Trophoblastic Disease Market Overview
  • 29.2. Africa Gestational Trophoblastic Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Gestational Trophoblastic Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Gestational Trophoblastic Disease Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Gestational Trophoblastic Disease Market Competitive Landscape And Company Profiles

  • 30.1. Gestational Trophoblastic Disease Market Competitive Landscape
  • 30.2. Gestational Trophoblastic Disease Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. F. Hoffmann-La Roche AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. AbbVie Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Bayer AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Novartis AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Gestational Trophoblastic Disease Market Other Major And Innovative Companies

  • 31.1. Merck And Co. Inc.
  • 31.2. Sun Pharmaceutical Industries Ltd.
  • 31.3. GSK plc
  • 31.4. Bristol-Myers Squibb Company
  • 31.5. Sanofi S.A.
  • 31.6. AstraZeneca plc
  • 31.7. Eli Lilly and Company
  • 31.8. Mylan N.V
  • 31.9. Daiichi Sankyo Co. Ltd.
  • 31.10. Eisai Co. Ltd.
  • 31.11. Perrigo Company plc
  • 31.12. Jiangsu Hengrui Medicine Co. Ltd.
  • 31.13. Exelixis Inc.
  • 31.14. Wockhardt Ltd.
  • 31.15. Natco Pharma Ltd.

32. Global Gestational Trophoblastic Disease Market Competitive Benchmarking

33. Global Gestational Trophoblastic Disease Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Gestational Trophoblastic Disease Market

35. Gestational Trophoblastic Disease Market Future Outlook and Potential Analysis

  • 35.1 Gestational Trophoblastic Disease Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Gestational Trophoblastic Disease Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Gestational Trophoblastic Disease Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer